Huntsman Cancer Institute-HCI Clinical Trials Office ( Site 1004)

Salt Lake City, Utah 84112

0 studies enrolling now · 1 studies all time

What they study most

Renal Cell Carcinoma

Studies at this site

• A Study of Belzutifan (MK-6482) in Combination With Palbociclib Versus Belzutifan Monotherapy in Participants With Advanced Renal Cell Carcinoma (MK-6482-024/LITESPARK-024) — Running, not enrolling